NOVARTIS: OVARIAN CANCER DRUG DISAPPOINTS IN TRIAL (AP)

May 27th, 2010    Posted by: Yahoo! News: Health News

AP – land take concern Novartis AG said weekday it won’t communicate regulators for authorisation to mart a newborn ovarian cancer take after a late-stage effort evidenced disappointing.

Comments are closed.

 

Navigation: